ADHD-Kid-Meditatin
‘Firmly embedded into our culture now, pharmaceutical companies create so-called cures and treatments for every human condition, and modern psychiatry has become an institution that works to create lifelong dependencies on medications to help people adapt to the stress of modern life and to conform to the rigid corporate/consumer culture that has come to be known as life.
Attention deficit hyperactivity disorder (ADHD) has become an industry in and of itself, and it is huge.
Attention deficit hyperactive disorder is big business. That’s the conclusion of a new report, published by the market research firm IBISWorld, which showed that ADHD medication sales have grown 8 percent each year since 2010 and will grow another 13 percent this year [2015] to $12.9 billion. Furthermore, it projects this growth will continue over the next five years at an annualized rate of 6 percent, and take in $17.5 billion in the year 2020—making it one of the top psychopharmaceutical categories on the market.’
Read more